Ashwagandha shows some promise for cholesterol management in early research, but the evidence is far from definitive. Lab studies demonstrate that its active compounds can reduce fat accumulation in liver cells, and a small number of human trials hint at modest lipid improvements. However, no large clinical trial has confirmed that ashwagandha reliably lowers cholesterol in people.
What the Lab Research Shows
The strongest evidence for ashwagandha’s effect on lipids comes from cell and animal studies, not human trials. Two compounds in ashwagandha, Withaferin A and Withanone, appear to dial down the liver’s fat-production machinery. In liver cells exposed to excess fatty acids, ashwagandha extracts reduced the activity of several proteins that drive fat creation, including one called fatty acid synthase and a master regulator of lipid metabolism known as SREBP-1c. Essentially, the compounds appear to tell liver cells to slow down the process of making and storing fat.
Withaferin A showed a stronger effect than Withanone in these experiments. In obese mice fed a high-fat diet, Withaferin A reduced liver inflammation, oxidative stress, and insulin resistance. These are all factors that contribute to poor cholesterol numbers in humans. But results in mice and isolated cells don’t automatically translate to what happens when a person takes an ashwagandha capsule.
What Human Studies Actually Found
Human evidence is thin. One double-blind, placebo-controlled pilot study in adults with overweight and obesity found that the ashwagandha group experienced a 32% decrease in their LDL-to-HDL cholesterol ratio. That sounds impressive, but the control group actually saw a larger drop of nearly 42% in LDL cholesterol on its own, making it difficult to attribute the changes specifically to ashwagandha. Pilot studies like this one involve small groups and are designed to test feasibility, not to prove effectiveness.
A separate eight-week study in young, healthy men taking ashwagandha alongside high-intensity interval training found no significant changes in total cholesterol, HDL, or LDL compared to placebo. Both groups saw statistically insignificant decreases across the board. In other words, ashwagandha added nothing measurable to what exercise alone was doing for their lipid profiles.
The bottom line from human data: no trial has yet demonstrated a clear, consistent cholesterol-lowering benefit from ashwagandha supplementation.
How Ashwagandha Might Affect Cholesterol Indirectly
One reason ashwagandha keeps appearing in cholesterol conversations is its well-documented effect on stress. Chronic stress raises cortisol, which promotes fat storage around the midsection and can worsen lipid profiles over time. If ashwagandha helps lower cortisol (which multiple trials support), it could theoretically improve cholesterol as a downstream effect. But this indirect pathway hasn’t been isolated or measured in a controlled cholesterol-focused study.
Similarly, ashwagandha’s anti-inflammatory and antioxidant properties could play a supporting role in cardiovascular health without directly lowering LDL or raising HDL. These benefits are real but nonspecific. They’re more like general housekeeping than targeted cholesterol management.
Dosage Used in Studies
Most clinical trials use between 300 and 700 mg of ashwagandha root extract per day, typically split into two doses. One well-documented trial protocol used 350 mg twice daily (700 mg total), with each capsule delivering about 2.5 mg of withanolides, the active compounds. Supplements vary widely in withanolide content, so the standardized percentage on the label matters more than the raw milligram count of the extract.
Studies measuring lipid changes have typically run for 8 to 12 weeks. If ashwagandha has any meaningful effect on cholesterol, it likely requires at least two months of consistent daily use before blood work would reflect a change.
Safety and Interactions
Ashwagandha has a solid short-term safety profile in clinical trials. In one study of healthy men taking 1,000 mg daily for a month, liver enzymes (ALT and AST) remained unchanged, and no serious side effects were reported. Across multiple trials, there have been no reports of liver damage during supplementation.
The more important concern is drug interactions. The National Institutes of Health notes that ashwagandha can interact with medications for diabetes, high blood pressure, thyroid conditions, and drugs that suppress the immune system. Notably, statins are not specifically listed among known interactions, but this area has not been thoroughly studied. If you’re already taking cholesterol medication, the combination hasn’t been tested for safety or effectiveness.
How Ashwagandha Compares to Proven Options
For context, prescription statins typically lower LDL cholesterol by 30% to 50%, with consistent results across large trials involving tens of thousands of participants. Lifestyle changes like regular aerobic exercise, reducing saturated fat intake, and increasing soluble fiber can lower LDL by 5% to 15%. Ashwagandha has no comparable body of evidence for cholesterol reduction.
If your primary goal is improving your lipid panel, ashwagandha is not a substitute for diet, exercise, or medication with proven track records. It may offer other benefits like stress reduction and better sleep that indirectly support heart health, but calling it a cholesterol supplement overstates what the current science supports.